Clinical Trial Update: Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Riboflavin/Dextran or Riboflavin/Methylcellulose [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for corneal collagen crosslinking with riboflavin/dextran or riboflavin/methylcellulose in keratoconus and corneal ectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• riboflavin/dextran (riboflavin/dextran)
• riboflavin/methylcellulose (riboflavin/methylcellulose)

Snippet

Sponsor: Cornea and Laser Eye Institute | Conditions: Keratoconus, Corneal Ectasia | Phase 3 | Status: UNKNOWN